Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11667905 Cysteine protease

Patent 11667905 was granted and assigned to Hansa Biopharma on June, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Hansa Biopharma

0

Current Assignee

Hansa Biopharma

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 6, 2023

0

Patent Application Number

176443150

Date Filed

December 14, 2021

0

Patent Citations

US Patent 10696959 Cysteine protease

0

US Patent 11214784 Cysteine protease

0

Patent Citations Received

US Patent 12129499 Protease variants and uses thereof

0

US Patent 12091694 Fc fusion molecules and uses thereof

0

Patent Primary Examiner

Tekchand Saidha

0

The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11667905 Cysteine protease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.